COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 31: Articles 301-310  | Next

A longitudinal study of anxiety and depression in Belgium during and after the COVID-19 pandemic
Bui, T., Demarest, S., Duveau, C., Hermans, L., Van Hal, G.
10.64898/2026.02.24.26347039 — Posted: 2026-02-26
Associations between SARS-CoV-2 Infection and Multidimensional Sleep Health
Batool-anwar, S., Weaver, M., Czeisler, M., Booker, L., Howard, M., Jackson, M., McDonald, C., Robbins, R., Verma, P., Rajaratnam, S., Czeisler, C., Quan, S. F.
10.64898/2026.02.19.26346546 — Posted: 2026-02-25
Circadian immunometabolic states impart a temporal response to SARS-CoV-2 spike proteins in mammalian macrophages
Buel, S. M., Balaraman, J., Jankowski, M. S., Hixson, K. K., Gao, Y., Kim, Y.-m., Munoz, N., Kyle, J. E., Lipton, M. S., Nicora, C. D., Piehowski, P. D., Baker, S. E., Hurley, J. M.
10.64898/2026.02.24.707668 — Posted: 2026-02-25
Identification of MED13 and DDX60 as critical host factors for SARS-CoV-2 infections
Kwon, H., Wai, S. T., Michlits, G., Dyczynski, M., Markovic, A., Rocha Berger, A. S. B., JOHN, L., Horn, M., Weber, F., Penninger, J. M., Monteil, V., Mirazimi, A.
10.64898/2026.02.25.707691 — Posted: 2026-02-25
Bayesian generative modeling for heterogeneous wastewater data applied to COVID-19 forecasting
Johnson, K. E., Vega Yon, G., Brand, S. P. C., Bernal Zelaya, C., Bayer, D., Volkov, I., Susswein, Z., Magee, A., Gostic, K. M., English, K. M., Ghinai, I., Hamlet, A., Olesen, S. W., Pulliam, J., Abbott, S., Morris, D. H.
10.64898/2026.02.23.26346887 — Posted: 2026-02-24
Alcov2: a National Questionnaire Survey for Understanding the Transmission of SARS-CoV-2 in French Households during First Lockdown
Lambert, A., Bonnet, A., Clavier, P., Biousse, P., Clavieres, L., Brouillet, S., Chachay, S., Jauffret-Roustide, M., Lewycka, S., Chesneau, N., Nuel, G.
10.64898/2026.02.23.26344954 — Posted: 2026-02-24
Automated Model Discovery Based on COVID-19 Epidemiologic Data
Babazadeh Shareh, M., Kleiner, F., Böhme, M., Hägele, C., Dickmann, P., Heintzmann, R.
10.64898/2026.02.22.26346850 — Posted: 2026-02-24
AVE0991, a Mas receptor agonist, increases influenza and COVID-19 severity in vivo.
Wu, M., Sng, J. D. J., Noye, E. C., McCallum, G., Bielefeldt-Ohmann, H., Foo, C. X., Ronacher, K., Chew, K. Y., Short, K. R.
10.64898/2026.02.23.707600 — Posted: 2026-02-24
Genetic Evidence Indicates the Evolutionary Importance of the SARS-CoV-2 ORF9b protein
Hisner, R., Martin, D. P.
10.64898/2026.02.23.707522 — Posted: 2026-02-24
Reclaiming health: a qualitative, explorative study of long covid recovery journeys involving mind-body approaches.
Deurman, C., Brinkman, V., Slagboom, M., Bussemaker, J., Vos, H. M. M.
10.64898/2026.02.21.26345052 — Posted: 2026-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).